Abstract
The aim of this study was to estimate the incidence of lost to follow up from anti-retroviral therapy (ART) care and identify the associated factors among human immunodeficiency virus (HIV) infected patients after first-line ART initiation at University of Gondar comprehensive specialized hospital, Northwest Ethiopia between January 2012 and January 2018. The overall incidence rate of lost to follow up was 12.26 per 100 person years (95% CI (10.61-14.18)). Being underweight (< 18.5 kg/m2) (AHR, 1.52, 95% CI 1.01-2.28), jobless (AHR, 2.22, 95% CI 1.2-4.11), substance abuser (AHR, 1.84 95% CI 1.19-2.86), having sub-optimal adherence (fair/poor) (AHR 6.33, 95% CI (3.90-10.26)), not receiving isoniazid prophylaxis (AHR 2.47, 95% CI (1.36-4.48)), ambulatory functional status (AHR 1.94, 95% CI (1.23-3.06)), having opportunistic infections (AHR, 1.74 95% CI 1.11-2.72), having CD4 count 201-349 cells/µL (AHR 0.58, 95% CI (0.38-0.88)) were found to be significant predictors of lost to follow up from ART service.
References
Nov 14, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Geetanjali ChanderRichard D Moore
Jun 6, 2009·PloS One·Martin W G BrinkhofMatthias Egger
Jun 9, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ingrid V BassettKenneth A Freedberg
Jul 14, 2010·Tropical Medicine & International Health : TM & IH·Matthew P Fox, Sydney Rosen
Sep 25, 2010·Bulletin of the World Health Organization·Vincent Ochieng-OokoPaula Braitstein
Mar 8, 2011·PloS One·Gilles Van CutsemAndrew Boulle
Sep 27, 2012·Journal of the International AIDS Society·Solomon OdafeOtto N Chabikuli
Mar 26, 2013·PloS One·Mamo WubshetYigzaw Kebede
Sep 7, 2013·The Pan African Medical Journal·Bayaki SakaPalokinam Vincent Pitché
Sep 14, 2013·Global Health Action·Gerardo Alvarez-UriaManoranjan Midde
Sep 26, 2013·PloS One·Dam Anh TranLei Zhang
Oct 29, 2013·BMJ Open·Bo Langhoff HøngeUNKNOWN Bissau HIV cohort study group
Dec 7, 2013·BMC Research Notes·Cavin Epie BekoloBasile Kollo
Jul 12, 2014·AIDS Care·Erik J BlutingerSunil S Solomon
Oct 16, 2014·North American Journal of Medical Sciences·Tezera Moshago BerhetoSalahuddin Mohammed
Jan 20, 2015·HIV Medicine·D P Webster
May 3, 2015·BMC Public Health·Zenebe MelakuElaine J Abrams
May 6, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew P Fox, Sydney Rosen
May 20, 2015·Current HIV Research·O O AgbajiPhyllis J Kanki
Jul 5, 2015·BMC Health Services Research·Mazvita Naome MberiRobert Summers
Jul 15, 2015·Journal of the International AIDS Society·Gabriela CarriquiryBryan Earl Shepherd
Nov 14, 2015·AIDS Care·V O Ojwang'C R Cohen
Feb 3, 2016·BMC Infectious Diseases·Stephen B AsiimweWinnie Muyindike
May 14, 2016·HIV/AIDS : Research and Palliative Care·Abebe MegersoZelalem Habtamu
Jun 9, 2016·PloS One·Yordanos M TirunehIra B Wilson
Jul 19, 2016·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Jan 21, 2017·PloS One·Hailay Abrha GesesewLillian Mwanri
Feb 1, 2017·PloS One·Julius Y FonsahGeorgette D Kanmogne
Jun 8, 2017·BMJ Global Health·Luchuo Engelbert BainJean Jacques N Noubiap
Oct 31, 2017·BMJ Global Health·Raffaella BucciardiniHagos Godefay
Dec 22, 2017·Indian Journal of Dermatology·Anupam DasNilay Kanti Das
May 12, 2018·BMC Research Notes·Moges Agazhe AssemieTadesse Awoke Ayele
Citations
Jan 25, 2020·PloS One·Achamyeleh Birhanu TeshaleHaileab Fekadu Wolde
Apr 15, 2020·AIDS·Elise M FrijtersJohn B F De Wit
Jun 24, 2020·BMC Infectious Diseases·Nurilign Abebe MogesYemane Berhane
Mar 9, 2021·AIDS Care·Noelle A BenzekriGeoffrey S Gottlieb
Feb 27, 2021·HIV/AIDS : Research and Palliative Care·Samuel DessuZinabu Dawit
Apr 29, 2021·HIV/AIDS : Research and Palliative Care·Demeke DejenBirhanu Wagaye
Aug 18, 2021·Global Health Action·Malin JohanssonPer Björkman
Nov 10, 2021·Expert Review of Anti-infective Therapy·Hossam AbdelazizWahid Doss